1What Is the A441 OHIP Code?
A441 is an OHIP billing code used by oncologists for complex medical specific re-assessments. These assessments are essential when patients exhibit multiple active issues, such as disease response, cumulative treatment toxicity, and comorbidities, all of which must be considered together to make informed treatment decisions.
This assessment may be necessary when evaluating whether to continue, modify, or discontinue a treatment regimen. The complexity arises in balancing the treatment's efficacy, potential side effects, and the patient's overall health condition, which requires a thorough and integrative approach.
Physicians may overlook using this code due to the complexity involved in determining the necessity of such a re-assessment or due to misunderstanding what qualifies for this specific assessment level.
2Related Codes
| Code | Name | Frequency | Description |
|---|---|---|---|
| A443 | Medical specific assessment | Subject to specialty-specific rules | $95.95 fee, used for medical oncology assessments. |
| C443 | Medical specific assessment | Subject to specialty-specific rules | $95.95 fee for hospital in-patient medical oncology assessments. |
| W444 | General re-assessment of patient in nursing home | Subject to specialty-specific rules | $20.60 fee for general re-assessment in nursing homes. |
| A444 | Medical specific re-assessment | Subject to specialty-specific rules | $72.00 fee for medical re-assessment in oncology. |
3Eligibility Requirements
To bill for A441, the complex medical re-assessment must consider multiple active issues requiring integration before making critical treatment decisions.
The service can be provided via virtual platforms, either through video or telephone, as detailed in Appendix J, Section 1 of the OHIP Schedule of Benefits. When delivered in a hospital in-patient setting, C441 should be billed instead.
Billing frequency is not strictly capped annually; however, it follows specialty-specific protocols and assessment rules. Physicians should consult the General Preamble and code-specific rules to ensure compliance.
4What Your Clinical Note Must Show
Proper documentation is crucial to justify the complexity of the assessment.
- Detailed patient history including treatment response.
- Assessment of cumulative toxicity.
- Review of comorbidities and integrated care plan.
- Clinical decision regarding treatment regimen changes.
5Weak vs. Strong Note Examples
The strong note is successful because it provides specific clinical details that justify the reassessment's complexity, whereas the weak note lacks depth and rationale.
Patient reviewed for treatment continuance.
No significant changes observed.
Patient presents with cumulative treatment-related fatigue and elevated liver enzymes.
Discussed potential modification of chemotherapy regimen to mitigate toxicity.
Considered patient's comorbid renal impairment in decision-making.
- Detailed clinical observations supporting complexity.
- Integration of clinical data affecting treatment decisions.
